These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

970 related articles for article (PubMed ID: 36765824)

  • 1. Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities.
    Pandey H; Tang DWT; Wong SH; Lal D
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
    John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
    J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer and gut microbiota studies in China.
    Wang Z; Dan W; Zhang N; Fang J; Yang Y
    Gut Microbes; 2023; 15(1):2236364. PubMed ID: 37482657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota, inflammatory bowel disease and colorectal cancer.
    Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
    World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three specific gut bacteria in the occurrence and development of colorectal cancer: a concerted effort.
    Gong D; Adomako-Bonsu AG; Wang M; Li J
    PeerJ; 2023; 11():e15777. PubMed ID: 37554340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications.
    Wong SH; Yu J
    Nat Rev Gastroenterol Hepatol; 2019 Nov; 16(11):690-704. PubMed ID: 31554963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota, Inflammation, and Colorectal Cancer.
    Brennan CA; Garrett WS
    Annu Rev Microbiol; 2016 Sep; 70():395-411. PubMed ID: 27607555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Role of Gut Microbiome in Colon Cancer.
    Chattopadhyay I; Dhar R; Pethusamy K; Seethy A; Srivastava T; Sah R; Sharma J; Karmakar S
    Appl Biochem Biotechnol; 2021 Jun; 193(6):1780-1799. PubMed ID: 33492552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies.
    Kang Y; Pan W; Cai Y
    Z Gastroenterol; 2017 Sep; 55(9):872-880. PubMed ID: 29186641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota in colorectal cancer related to liver metastasis.
    Wei P; Han W; Zhang Z; Tian X; Yang C; Wang Q; Xie W; Liu Y; Gao Y; Chang H
    Chin J Cancer Res; 2024 Feb; 36(1):17-24. PubMed ID: 38455371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer.
    Qu R; Zhang Y; Ma Y; Zhou X; Sun L; Jiang C; Zhang Z; Fu W
    Adv Sci (Weinh); 2023 Aug; 10(23):e2205563. PubMed ID: 37263983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer.
    Ahmad Kendong SM; Raja Ali RA; Nawawi KNM; Ahmad HF; Mokhtar NM
    Front Cell Infect Microbiol; 2021; 11():744606. PubMed ID: 34966694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota and their derivatives in the progression of colorectal cancer: Mechanisms of action, genome and epigenome contributions.
    Ahmad A; Mahmood N; Raza MA; Mushtaq Z; Saeed F; Afzaal M; Hussain M; Amjad HW; Al-Awadi HM
    Heliyon; 2024 Apr; 10(8):e29495. PubMed ID: 38655310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.
    Avuthu N; Guda C
    Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing
    Veziant J; Villéger R; Barnich N; Bonnet M
    Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34063108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of gut microbiota in the colorectal cancer and potential target therapy.
    Li J; Zhu Y; Yang L; Wang Z
    Discov Oncol; 2022 Jun; 13(1):51. PubMed ID: 35749000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metagenomic analysis of fecal samples in colorectal cancer Egyptians patients post colectomy: A pilot study.
    Abo-Hammam RH; Salah M; Shabayek S; Hanora A; Zakeer S; Khattab RH
    AIMS Microbiol; 2024; 10(1):148-160. PubMed ID: 38525041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review.
    Ranjbar M; Salehi R; Haghjooy Javanmard S; Rafiee L; Faraji H; Jafarpor S; Ferns GA; Ghayour-Mobarhan M; Manian M; Nedaeinia R
    Cancer Cell Int; 2021 Apr; 21(1):194. PubMed ID: 33823861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal microbiota, chronic inflammation, and colorectal cancer.
    Park CH; Eun CS; Han DS
    Intest Res; 2018 Jul; 16(3):338-345. PubMed ID: 30090032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiome: decision-makers in the microenvironment of colorectal cancer.
    Han J; Zhang B; Zhang Y; Yin T; Cui Y; Liu J; Yang Y; Song H; Shang D
    Front Cell Infect Microbiol; 2023; 13():1299977. PubMed ID: 38156313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.